Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaiba Mouthwash for Oral Mucositis in Oral Cancer Patients Undergoing Radiotherapy
NCT05308732Phase 1Completed
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- May 2021
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of copaiba in oral mucositis (OM), sponsored by Instituto Nacional de Câncer José Alencar Gomes da Silva. Primary endpoint: Maximum tolerated dose. Started May 2021; status: completed.
02
Drugs
copaiba
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT05308732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05308732.